Runx2 modified dental pulp stem cells (DPSCs) enhance new bone formation during rapid distraction osteogenesis (DO)

详细信息    查看全文

• 作者：Guijuan Feng^a ; ¹ ; Jinlong Zhang^b ; ¹ ; Xingmei Feng^a ; Senbin Wu^a ; Dan Huang^a ; Jing Hu^c ; Songsong Zhu^c ; Donghui Song^a ; ^{sdh527@163.com" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Distraction osteogenesis (DO) ; Dental pulp stem cells (DPSCs) ; Bone formation ; Runt-related gene 2 (Runx2)
• 刊名：Differentiation
• 出版年：2016
• 出版时间：October-November 2016
• 年：2016
• 卷：92
• 期：4
• 页码：195-203
• 全文大小：2661 K

文摘

Distraction osteogenesis (DO) remains a major challenge in orthopedic and craniofacial surgery. The transplantion of mesenchymal stem cells (MSCs) could reduce the treatment period and the associated complications by increasing new bone formation during long-bone DO. Runt-related transcription factor 2 (Runx2) encodes a nuclear protein that is a pivotal regulator of osteoblast differentiation. It significantly stimulates calcium accumulation and alkaline phosphatase (ALP) activity in dental pulp stem cells (DPSCs). In this study, we investigated the effects of gene therapy using Runx2 on new bone formation during tibia DO of rabbits. The distraction gap of the rabbits was injected with adenovirus (Adv)-Runx2-green fluorescent protein (GFP)-transfected DPSCs (overexpression group, Group OE) or Adv-GFP-transfected DPSCs (negative control group, Group NC). Rabbits in the control group (Groups CON) were injected with physiologic saline. The generation of new bone tissue in the distraction gap was studied by radiographic examination, micro-computed tomography (CT) evaluation, histological analyze, and Mechanical testing at weeks 8 in the consolidation period. Excellent bone formation in the distracted callus was observed in Group OE and Group NC. Moreover, the OE group showed better bone formation and the highest bone mineral density (BMD) and bone mineral content (BMC). Group CON animals showed inadequate bone formation in the distracted callus compared to the other groups. The results suggest that gene therapy using Runx2-modified DPSCs was more effective during bone deposition and new bone formation in tibia DO.